Searched for: in-biosketch:true
person:golfij01
A Prospective Observational Study Correlating Peripheral Biomarkers Associated with Changes to the Blood-Brain Barrier and Tumor Volume in Patients Treated with Radiation for Intracranial Metastases [Meeting Abstract]
Cooper, B. T.; Shenker, R. F.; Oh, C.; Tyburczy, A.; Golfinos, J.; Silverman, J. S.; Kondziolka, D.
ISI:000485671500164
ISSN: 0360-3016
CID: 4111312
Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using TERT promoter mutation-specific droplet digital PCR assays
Cordova, Christine; Syeda, Mahrukh M; Corless, Broderick; Wiggins, Jennifer M; Patel, Amie; Kurz, Sylvia Christine; Delara, Malcolm; Sawaged, Zacharia; Utate, Minerva; Placantonakis, Dimitris; Golfinos, John; Schafrick, Jessica; Silverman, Joshua Seth; Jain, Rajan; Snuderl, Matija; Zagzag, David; Shao, Yongzhao; Karlin-Neumann, George Alan; Polsky, David; Chi, Andrew S
ORIGINAL:0014231
ISSN: 1527-7755
CID: 4032352
A PHASE 0 PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF EVEROLIMUS IN VESTIBULAR SCHWANNOMA (VS) AND MENINGIOMA PATIENTS [Meeting Abstract]
Karajannis, Matthias; Goldberg, Judith; Roland, J. Thomas; Sen, Chandranath; Placantonakis, Dimitris; Golfinos, John; Allen, Jeffrey; Dunbar, Erin; Plotkin, Scott; Akshintala, Srivandana; Schneider, Robert; Deng, Jingjing; Neubert, Thomas A.; Giancotti, Filippo; Zagzag, David; Blakeley, Jaishri O.
ISI:000509478700053
ISSN: 1522-8517
CID: 4511792
NONINVASIVE PERFUSION IMAGING BIOMARKER OF MALIGNANT GENOTYPE IN ISOCITRATE DEHYDROGENASE MUTANT GLIOMAS [Meeting Abstract]
Mureb, Monica; Jain, Rajan; Poisson, Laila; Littig, Ingrid Aguiar; Neto, Lucidio Nunes; Wu, Chih-Chin; Ng, Victor; Patel, Sohil; Patel, Seema; Serrano, Jonathan; Kurz, Sylvia; Cahill, Daniel; Bendszus, Martin; von Deimling, Andreas; Placantonakis, Dimitris; Golfinos, John; Kickingereder, Philipp; Snuderl, Matija; Chi, Andrew
ISI:000509478703153
ISSN: 1522-8517
CID: 4530372
A PHASE 0 PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF EVEROLIMUS IN VESTIBULAR SCHWANNOMA (VS) AND MENINGIOMA PATIENTS [Meeting Abstract]
Karajannis, Matthias; Wang, Shiyang; Goldberg, Judith; Roland, Thomas; Sen, Chandranath; Placantonakis, Dimitris; Golfinos, John; Allen, Jeffrey; Dunbar, Erin; Plotkin, Scott; Akshintala, Srivandana; Schneider, Robert; Deng, Jingjing; Neubert, Thomas; Giancotti, Filippo; Blakeley, Jaishri
ISI:000473243700215
ISSN: 1522-8517
CID: 4511782
Comparing costs of microsurgical resection and stereotactic radiosurgery for vestibular schwannoma
Schnurman, Zane; Golfinos, John G; Epstein, David; Friedmann, David R; Roland, J Thomas; Kondziolka, Douglas
OBJECTIVE:Given rising scrutiny of healthcare expenditures, understanding intervention costs is increasingly important. This study aimed to compare and characterize costs for vestibular schwannoma (VS) management with microsurgery and radiosurgery to inform practice decisions and appraise cost reduction strategies. METHODS:In conjunction with medical records, internal hospital financial data were used to evaluate costs. Total cost was divided into index costs (costs from arrival through discharge for initial intervention) and follow-up costs (through 36 months) for 317 patients with unilateral VSs undergoing initial management between June 2011 and December 2015. A retrospective matched cohort based on tumor size with 176 patients (88 undergoing each intervention) was created to objectively compare costs between microsurgery and radiosurgery. The full sample of 203 patients treated with resection and 114 patients who underwent radiosurgery was used to evaluate a broad range of outcomes and identify cost contributors within each intervention group. RESULTS:Within the matched cohort, average index costs were significantly higher for microsurgery (100% by definition, because costs are presented as a percentage of the average index cost for the matched microsurgery group; 95% CI 93-107) compared to radiosurgery (38%, 95% CI 38-39). Microsurgery had higher average follow-up costs (1.6% per month, 95% CI 0.8%-2.4%) compared to radiosurgery (0.5% per month, 95% CI 0.4%-0.7%), largely due to costs incurred in the initial months after resection. A major contributor to total cost and cost variability for both resection and radiosurgery was the need for additional interventions in the follow-up period, which were necessary due to complications or persistent functional deficits. Although tumor size was not associated with increased total costs for radiosurgery, linear regression analysis demonstrated that, for patients who underwent microsurgery, each centimeter increase in tumor maximum diameter resulted in an estimated increase in total cost of 50.2% of the average index cost of microsurgery (95% CI 34.6%-65.7%) (p < 0.001, R2 = 0.17). There were no cost differences associated with the proportion of inpatient days in the ICU or with specific surgical approach for patients who underwent resection. CONCLUSIONS:This study is the largest assessment to date based on internal cost data comparing VS management with microsurgery and radiosurgery. Both index and follow-up costs are significantly higher when tumors were managed with resection compared to radiosurgery. Larger tumors were associated with increased resection costs, highlighting the incremental costs associated with observation as the initial management.
PMID: 30497146
ISSN: 1933-0693
CID: 4168992
Knowledge silos: assessing knowledge sharing between specialties through the vestibular schwannoma literature
Schnurman, Zane; Golfinos, John G; Roland, J Thomas Jr; Kondziolka, Douglas
OBJECTIVE It is common for a medical disorder to be managed or researched by individuals who work within different specialties. It is known that both neurosurgeons and neurotologists manage vestibular schwannoma (VS) patients. While overlap in specialty focus has the potential to stimulate multidisciplinary collaboration and innovative thinking, there is a risk of specialties forming closed-communication loops, called knowledge silos, which may inhibit knowledge diffusion. This study quantitatively assessed knowledge sharing between neurosurgery and otolaryngology on the subject of VS. METHODS A broad Web of Science search was used to download details for 4439 articles related to VS through 2016. The publishing journal's specialty and the authors' specialties (based on author department) were determined for available articles. All 114,647 of the article references were categorized by journal specialty. The prevalence of several VS topics was assessed using keyword searches of titles. RESULTS For articles written by neurosurgeons, 44.0% of citations were from neurosurgery journal articles and 23.4% were from otolaryngology journals. The citations of otolaryngology authors included 11.6% neurosurgery journals and 56.5% otolaryngology journals. Both author specialty and journal specialty led to more citations of the same specialty, though author specialty had the largest effect. Comparing the specialties' literature, several VS topics had significantly different levels of coverage, including radiosurgery and hearing topics. Despite the availability of the Internet, there has been no change in the proportions of references for either specialty since 1997 (the year PubMed became publicly available). CONCLUSIONS Partial knowledge silos are observed between neurosurgery and otolaryngology on the topic of VS, based on the peer-reviewed literature. The increase in access provided by the Internet and searchable online databases has not decreased specialty reference bias. These findings offer lessons to improve cross-specialty collaboration, physician learning, and consensus building.
PMID: 29192857
ISSN: 1933-0693
CID: 2797962
Clinically aggressive meningiomas are characterized by mutational signatures associated with defective DNA repair and mutations in chromatin remodeling genes [Meeting Abstract]
Kurz, S; Liechty, B; Kelly, S; Vasudevaraja, V; Bledea, R; Wu, P; Serrano, J; Katz, L M; Silverman, J; Pacione, D; Golfinos, J; Chi, A; Snuderl, M
BACKGROUND: Up to 20% of meningiomas are aggressive tumors with high recurrence rates and poor prognosis. Biomarkers predicting the risk of an unfavorable clinical course are lacking although aberrations in NF2, increased copy number variations and a hypomethylated phenotype have been associated with more aggressive behavior. Mutational signatures (MS) are characteristic patterns of somatic mutations seen in cancer genomes associated with aging, exposure to certain mutagens, or defective DNA repair. We aimed to identify MS patterns in clinically aggressive meningiomas.
METHOD(S): We performed whole exome sequencing of 18 de novo meningiomas (locally invasive and recurrent WHO I, n=6; atypical WHO II, n=4; anaplastic WHO III, n=8). Median PFS was 18.9 months. Copy numbers and DNA methylation phenotype were assessed by DNA methylation array analysis. Mutational signatures were identified using published signature algorithms (COSMIC).
RESULT(S): MS1 and MS5 (aging) were found in 18 (100%) cases. MS associated with defective DNA MMR were highly prevalent: MS20 and MS26 were detected in 18 (100%) and MS6 in 2 (12%) cases. MS12 (unknown etiology) was present in 14 (82%) cases. Despite the association with defective DNA MMR, none (0%) of the MS6 cases harbored somatic mutations associated with DNA MMR while MS12 tumors were enriched for mutations in DNA MMR (43%), chromatin remodeling (36%) and other cancer-associated genes (7%). MS6 tumors had significantly lower indels compared to non-MS6 tumors (p=0.01). Tumors with mutations in chromatin remodeling genes had a significantly higher rate of single nucleotide variants (SNVs) compared to cases without such mutations (p=0.02).
CONCLUSION(S): MS associated with defective DNA MMR were highly prevalent in this set of aggressive meningiomas. However, despite the association with DNA MMR, MS6 meningiomas harbored no somatic mutations associated with DNA MMR while MS12 tumors were enriched for mutations in DNA MMR, chromatin remodeling and cancerassociated genes
EMBASE:628634781
ISSN: 1523-5866
CID: 4021772
Loss of histone H3K27ME3 identifies a subset of meningiomas with increased risk of recurrence [Meeting Abstract]
Katz, L M; Hielscher, T; Liechty, B; Silverman, J; Zagzag, D; Sen, R; Wu, P; Golfinos, J; Reuss, D; Neidert, M; Wirsching, H -G; Baumgarten, P; Herold-Mende, C; Wick, W; Harter, P; Weller, M; Von, Deimling A; Snuderl, M; Sen, C; Sahm, F
Epigenetic patterns on the level of DNA methylation have already shown to separate clinically relevant subgroups of meningiomas. Based on a reference set (Sahm et al., Lancet Oncol 2017), an epigenetic meningioma classifier employing DNA methylation patterns is made available through molecularneurpathology.org. We now set out to identify prognostic implications of epigenetic modification on the proteome level, particularly modifications of histones. First focus was on H3K27 trimethylation (H3K27me3). H3K27me3 was assessed by immunohistochemistry on 232 meningiomas. In 194 cases, trimethylation was detected in tumor cells. In 25 cases, staining was limited to vessels while all tumor cells were negative. Finally, 13 cases yielded equivocal staining patterns. Reduced abundance of H3K27me3 in cases with staining limited to vessels was confirmed by mass spectrometry on a subset of cases. Lack of staining for H3K27me3 in all tumor cells was significantly associated with more rapid progression (p=0.009). In line, H3K27me3 negative cases were associated with a DNA methylation pattern of the more aggressive types among the recently introduced DNA methylation groups. Also, NF2 and SUFU mutations were enriched among cases with lack of H3K27me3 in tumor cells (p<0.0001 and p=0.029, respectively). H3K27me3 staining pattern added significant prognostic insight in WHO grade II cases and in the compound subset of WHO grade I and II cases (p=0.04 and p=0.007, respectively). However, it did not further stratify within WHO grade III cases. Collectively, this data indicate that epigenetic modifications beyond DNA methylation are involved in the aggressiveness of meningioma. It also suggests that H3K27me3 immunohistochemistry might be a useful adjunct in meningioma diagnostics, particularly for cases with WHO grade II histology or at the borderline between WHO grade I and II. Ongoing studies evaluate the role of histone marks other than H3K27me3 and consequences on the proteomic composition of meningioma cells by high-throughput mass spectrometry
EMBASE:628634518
ISSN: 1523-5866
CID: 4021812
Postoperative cerebral venous sinus thrombosis in the setting of surgery adjacent to the major dural venous sinuses
Benjamin, Carolina Gesteira; Sen, Rajeev D; Golfinos, John G; Sen, Chandra; Roland, J Thomas; McMenomey, Sean; Pacione, Donato
OBJECTIVECerebral venous sinus thrombosis (CVST) is a known complication of surgeries near the major dural venous sinuses. While the majority of CVSTs are asymptomatic, severe sinus thromboses can have devastating consequences. The objective of this study was to prospectively evaluate the true incidence and risk factors associated with postoperative CVST and comment on management strategies.METHODSA prospective study of 74 patients who underwent a retrosigmoid, translabyrinthine, or suboccipital approach for posterior fossa tumors, or a supratentorial craniotomy for parasagittal/falcine tumors, was performed. All patients underwent pre- and postoperative imaging to evaluate sinus patency. Demographic, clinical, and operative data were collected. Statistical analysis was performed to identify incidence and risk factors.RESULTSTwenty-four (32.4%) of 74 patients had postoperative MR venograms confirming CVST, and all were asymptomatic. No risk factors, including age (p = 0.352), BMI (p = 0.454), sex (p = 0.955), surgical approach (p = 0.909), length of surgery (p = 0.785), fluid balance (p = 0.943), mannitol use (p = 0.136), tumor type (p = 0.46, p = 0.321), or extent of resection (p = 0.253), were statistically correlated with thrombosis. All patients were treated conservatively, with only 1 patient receiving intravenous fluids. There were no instances of venous infarctions, hemorrhages, or neurological deficits. The rate of CSF leakage was significantly higher in the thrombosis group than in the nonthrombosis group (p = 0.01).CONCLUSIONSThis prospective study shows that the radiographic incidence of postoperative CVST is higher than that previously reported in retrospective studies. In the absence of symptoms, these thromboses can be treated conservatively. While no risk factors were identified, there may be an association between postoperative CVST and CSF leak.
PMID: 30497227
ISSN: 1933-0693
CID: 4132812